The purpose of this study is to evaluate the safety and effectiveness of an experimental device called the TIVUS System to treat people who have hypertension (high blood pressure) that is not controlled despite treatment with blood pressure medications. Individuals with controlled blood pressure who are willing to come off their blood pressure medications for the purpose of being in this study may also participate. The study aims to determine whether the device, which uses sound waves (ultrasonic energy) to heat up and impair some of the nerves around the arteries leading to the kidneys, will control blood pressure as well as or better than using medication. The information collected from this study will be used to evaluate how well participants do when treated with the TIVUS system both immediately after treatment and over a longer period of time (3 years). Procedures include angiograms, ultrasounds, blood and urine collection, and a possible procedure in which an ultrasound catheter is placed in the kidney’s main artery to deliver a short pulse of heat. Participants will be randomly assigned to either the treatment group using the TIVUS system or to the sham group (no treatment). For every 2 patients treated with TIVUS system, 1 will be assigned to the sham group; participants will have approximately a 67% chance of receiving treatment with the TIVUS system. Blood pressure-lowering medications will eventually be restarted during the study, and participants who received the sham procedure may have the chance to receive renal denervation with the TIVUS system after approximately 6 months of study participation.
What is the full name of this clinical trial?
A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled, Study Comparing the Therapeutic Intravascular Ultrasound Renal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension .